It’s worth mentioning that the plan also lowers the corporate tax rate to 20% and moves to a territorial tax system, provisions that will have a huge impact on the U.S. pharmaceutical industry, allowing biotech and pharmaceutical companies to repatriate their overseas profits without penalty, thereby increasing investment in domestic pharmaceutical R&D.
http://www.forbes.com/sites/aroy/201...health-reform/
This just keeps getting better, but I'm sure there will be a bump somewhere. Have to see how Newt's plan fleshes out as well. He's my second choice.
Threaded Mode
